Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC; Frankfurt:3CM), a leading business technology company in the cannabis space, is pleased to announce the appointment of Shirish Patel, MD to its Health and Innovation Advisory Board. The Health and Innovation Advisory Board oversees all content related to the Cannvas.me platform, a scalable solution for the global medical cannabis community offering interactive tools, educational modules and physician-backed content to audiences wishing to learn about healthcare through cannabis.
“I am delighted to join Cannvas’ Health and Innovation Advisory Board in an effort to continue to bring the health and wellness benefits of cannabis to patients in Canada and around the world,” said Shirish Patel, MD. “As a medical advisor for a concierge medical cannabis clinic in Toronto, I witness the benefits of medical cannabis on a regular basis. I also strongly believe that technology can play an important role in the delivery and education of medical cannabis leading improved patient outcomes. The Cannvas.me online platform will have global reach and be able to provide patients and doctors with knowledge and education on an international basis. I look forward to working with the Cannvas team on this important project.”
“We are honoured to have Dr. Patel join our Health and Innovation Advisory Board as we prepare to launch Cannvas.me, our solution to medical cannabis information and education,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “Dr. Patel is a highly respected and accomplished medical doctor and researcher with considerable experience with leveraging technology to improve the healthcare system in Canada and the United States. He is a valuable addition to the advisory board and I look forward to collaborating with Dr. Patel to bring advanced technology to the medical cannabis space.”
Dr. Patel is an engineer-turned-clinician with a passion for neurology, psychiatry, immunology, pharmacology, pharmacogenomics, and electronic healthcare delivery. For the past three years he has been working as a Neuropsychiatric Intake Specialist and Counselor for a private psychosomatic psychiatry clinic located in Toronto, Ontario. He also works as the medical advisor for My Natural Living Life, a concierge medical cannabis clinic and most recently took on a concurrent role as the Medical Advisor for health informatics & measurement-based care with Trendlines Health Inc., a company specializing in remote data acquisition from wearable health devices for data consolidation and analysis.
Dr. Patel strengths lie in the scientific exchange and translation from clinical research to help support health care providers with clinical decision making skills. As a skilled researcher he is authoring and co-authoring several articles for publications covering topics including mobile mental health technology, neurobiology, and neurodevelopmental disorders. In 2018, Dr. Patel has presented a total of five scientific posters at the American Psychiatric Association (APA) annual meeting, developed in collaboration with leading psychiatrists and psychiatry residents from Canada and the U.S.
Cannvas.me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about healthcare through cannabis. Its Cannvas Academy, already guided by its Medical Advisory Board, will receive additional oversight and direction from the Education Advisory Panel, made up of highly qualified members from industry and government institutions.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com; Media Inquiries, firstname.lastname@example.org; Investor Relations, email@example.com, 1-800-489-0116
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact firstname.lastname@example.org, or